Sorry, you need to enable JavaScript to visit this website.
Open Menu
icone
Obesity

Information for healthcare professionals on obesity including guidelines, protocols and evidence on the use of VLCDs.

Butsch WS et al. 2025 Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study

In this retrospective observational study it examines the increased nutritional risks in adults who undergo GLP-1 RA therapy, including those with type 2 diabetes, prediabetes, and obesity.